Latest Innovation News

Nufarm reported a mixed 1H25 result with a strong rebound in crop protection profits contrasting a steep decline in seed technologies earnings, prompting a strategic review of the latter business.

Catapult Group International Ltd reported a milestone FY25 with ACV exceeding US$100 million, driven by strong SaaS growth and record profitability. The company’s innovative product launches and improved cost efficiencies underpin a confident outlook for FY26.

Catapult Group International has reported a milestone FY25, surpassing US$100 million in Annualized Contract Value and delivering a record US$8.6 million in free cash flow, underscoring its growing dominance in sports technology.

Catapult Group International Ltd reported a 16.5% increase in revenue to $116.5 million for FY25, driven by strong subscription growth and improved operational efficiency. The company narrowed its net loss after tax to $8.8 million, signaling progress in its global sports technology strategy.

Ardea Resources has received a $1.2 million R&D tax incentive rebate from the Australian Government, reinforcing its innovative work at the Kalgoorlie Nickel Project and strengthening its financial position.

Tempest Minerals has enhanced geochemical sampling at its Sanity Prospect within the Yalgoo Project, confirming a robust gold anomaly and setting the stage for targeted drilling.

SGH Ltd has reaffirmed its FY25 guidance for high single-digit EBIT growth while targeting a net debt to EBITDA ratio of 2.0x by year-end, underpinned by disciplined capital allocation and operational improvements across its diversified industrial, energy, and media businesses.

Merino & Co has amended its quarterly report to correct expenditure figures and clarify related party payments, while reporting significant operational progress including new product launches and cryptocurrency integration.

Nanollose has successfully placed the $1.05 million shortfall from its recent entitlement offer, bolstering its capital to advance production and commercialisation of its innovative biomaterials.

Zoono Group has inked a five-year exclusive contract with Sharpak and OSY to apply its antimicrobial technology on UK soft fruit packaging, aiming to reduce food waste and boost shelf-life.

Clarity Pharmaceuticals has initiated its second registrational Phase III AMPLIFY trial for the Cu-SAR-bisPSMA PET imaging agent targeting biochemical recurrence of prostate cancer. The multi-centre study aims to generate critical data supporting FDA approval and could redefine prostate cancer diagnostics.

Dotz Nano Limited has announced a A$1.2 million private placement at a discounted share price, accompanied by options, to bolster working capital and support the commercialisation of its carbon capture technology.